[(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
CAS: 62820-11-5
Ref. 3D-MCA82011
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- 2-Propenoic acid, 3-phenyl-, (1aS,1bR,2S,3S,4aR,6E,7aR,8aS,10aR)-1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, (2E)-
- 2-Propenoic acid, 3-phenyl-, 1a,1b,2,3,4,5,7a,8,8a,9,10,10a-dodecahydro-2-hydroxy-6-(hydroxymethyl)-3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxiren-4a-yl ester, [1aS-[1aR*,1bS*,2R*,3R*,4aS*(E),6E,7aS*,8aR*,10aS*]]-
- Jolkinol A
- 4aH-Cyclopenta[3,4]cyclopropa[8,9]cycloundec[1,2-b]oxirene, 2-propenoic acid deriv.
(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate is a skeleton that contains a mixture of daphnine and lathyris diterpenes. It has been shown to have antitumour activity in both rodent models and in human cancer cells. The biological properties of this compound are being investigated further. This compound is known to be an inhibitor of translation and transcription by binding to the ribosome and inhibiting protein synthesis at the translational level. [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl
Propiedades químicas
Consulta técnica sobre: 3D-MCA82011 [(1S,4R,7S,9R,13R)-16-Hydroxy-11-(hydroxymethyl)-4,8,8,15-tetramethyl-12-oxo-3-oxatetracyclo[11.3.0.02,4.07,9]hexadec-10-en-13-yl] 3 -phenylprop-2-enoate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
